FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387616475> ?p ?o ?g. }

• W4387616475 endingPage "2458" @default.
• W4387616475 startingPage "2458" @default.
• W4387616475 abstract "Following its therapeutic effect in hematological metastasis, chimeric antigen receptor (CAR) T cell therapy has gained a great deal of attention during the last years. However, the effectiveness of this treatment has been hampered by a number of challenges, including significant toxicities, difficult access to tumor locations, inadequate therapeutic persistence, and manufacturing problems. Developing novel techniques to produce effective CARs, administer them, and monitor their anti-tumor activity in CAR-T cell treatment is undoubtedly necessary. Exploiting the advantages of nanotechnology may possibly be a useful strategy to increase the efficacy of CAR-T cell treatment. This study outlines the current drawbacks of CAR-T immunotherapy and identifies promising developments and significant benefits of using nanotechnology in order to introduce CAR transgene motifs into primary T cells, promote T cell expansion, enhance T cell trafficking, promote intrinsic T cell activity and rewire the immunosuppressive cellular and vascular microenvironments. Therefore, the development of powerful CART cells can be made possible with genetic and functional alterations supported by nanotechnology. In this review, we discuss the innovative and possible uses of nanotechnology for clinical translation, including the delivery, engineering, execution, and modulation of immune functions to enhance and optimize the anti-tumor efficacy of CAR-T cell treatment." @default.
• W4387616475 created "2023-10-14" @default.
• W4387616475 creator A5016553741 @default.
• W4387616475 creator A5019228371 @default.
• W4387616475 creator A5023267482 @default.
• W4387616475 creator A5027834835 @default.
• W4387616475 creator A5027879139 @default.
• W4387616475 creator A5037104427 @default.
• W4387616475 creator A5037835689 @default.
• W4387616475 creator A5062609773 @default.
• W4387616475 creator A5065010001 @default.
• W4387616475 creator A5066445455 @default.
• W4387616475 creator A5070078324 @default.
• W4387616475 creator A5074122225 @default.
• W4387616475 creator A5079063229 @default.
• W4387616475 creator A5080024937 @default.
• W4387616475 creator A5084832305 @default.
• W4387616475 creator A5089800113 @default.
• W4387616475 creator A5090493090 @default.
• W4387616475 creator A5091910847 @default.
• W4387616475 date "2023-10-13" @default.
• W4387616475 modified "2023-10-15" @default.
• W4387616475 title "Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery" @default.
• W4387616475 cites W1817778246 @default.
• W4387616475 cites W1910012553 @default.
• W4387616475 cites W1966082198 @default.
• W4387616475 cites W2127909767 @default.
• W4387616475 cites W2229738114 @default.
• W4387616475 cites W2398597901 @default.
• W4387616475 cites W2607356458 @default.
• W4387616475 cites W2749329560 @default.
• W4387616475 cites W2783589844 @default.
• W4387616475 cites W2792588868 @default.
• W4387616475 cites W2803257972 @default.
• W4387616475 cites W2807276288 @default.
• W4387616475 cites W2889863283 @default.
• W4387616475 cites W2898096094 @default.
• W4387616475 cites W2901262057 @default.
• W4387616475 cites W2904297611 @default.
• W4387616475 cites W2910846547 @default.
• W4387616475 cites W2911543360 @default.
• W4387616475 cites W2936551248 @default.
• W4387616475 cites W2964377482 @default.
• W4387616475 cites W2987601351 @default.
• W4387616475 cites W2987798976 @default.
• W4387616475 cites W2995900562 @default.
• W4387616475 cites W2998352028 @default.
• W4387616475 cites W2999972782 @default.
• W4387616475 cites W3006716329 @default.
• W4387616475 cites W3011938080 @default.
• W4387616475 cites W3016152816 @default.
• W4387616475 cites W3046025665 @default.
• W4387616475 cites W3084667850 @default.
• W4387616475 cites W3085241535 @default.
• W4387616475 cites W3095258059 @default.
• W4387616475 cites W3102474194 @default.
• W4387616475 cites W3107786127 @default.
• W4387616475 cites W3108915721 @default.
• W4387616475 cites W3124142499 @default.
• W4387616475 cites W3124631812 @default.
• W4387616475 cites W3126210657 @default.
• W4387616475 cites W3126604828 @default.
• W4387616475 cites W3132062361 @default.
• W4387616475 cites W3133009566 @default.
• W4387616475 cites W3158029302 @default.
• W4387616475 cites W3162374648 @default.
• W4387616475 cites W3164577482 @default.
• W4387616475 cites W3189756293 @default.
• W4387616475 cites W3198281874 @default.
• W4387616475 cites W3200604042 @default.
• W4387616475 cites W3207676521 @default.
• W4387616475 cites W3208732515 @default.
• W4387616475 cites W3211754161 @default.
• W4387616475 cites W3215836775 @default.
• W4387616475 cites W4200034359 @default.
• W4387616475 cites W4205237319 @default.
• W4387616475 cites W4214859401 @default.
• W4387616475 cites W4220655611 @default.
• W4387616475 cites W4220664557 @default.
• W4387616475 cites W4220766750 @default.
• W4387616475 cites W4223521732 @default.
• W4387616475 cites W4226203376 @default.
• W4387616475 cites W4229048322 @default.
• W4387616475 cites W4280509433 @default.
• W4387616475 cites W4281489901 @default.
• W4387616475 cites W4281961745 @default.
• W4387616475 cites W4281965930 @default.
• W4387616475 cites W4286697597 @default.
• W4387616475 cites W4292284023 @default.
• W4387616475 cites W4295222616 @default.
• W4387616475 cites W4295737738 @default.
• W4387616475 cites W4295752650 @default.
• W4387616475 cites W4296177288 @default.
• W4387616475 cites W4297540281 @default.
• W4387616475 cites W4303645565 @default.
• W4387616475 cites W4304014325 @default.
• W4387616475 cites W4306773867 @default.
• W4387616475 cites W4309309493 @default.

• next